SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-079008
Filing Date
2015-03-05
Accepted
2015-03-05 17:14:01
Documents
13
Period of Report
2015-03-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d884922d8k.htm 8-K 27142
2 EX-2.1 d884922dex21.htm EX-2.1 409879
3 EX-99.1 d884922dex991.htm EX-99.1 26610
4 EX-99.2 d884922dex992.htm EX-99.2 51125
5 GRAPHIC g884922ex99_2s1gbgd.jpg GRAPHIC 23015
6 GRAPHIC g884922ex99_2s2gbgd.jpg GRAPHIC 28542
7 GRAPHIC g884922ex99_2s3gbgd.jpg GRAPHIC 28898
8 GRAPHIC g884922ex99_2s4gbgd.jpg GRAPHIC 31217
9 GRAPHIC g884922ex99_2s5gbgd.jpg GRAPHIC 38219
10 GRAPHIC g884922ex99_2s6gbgd.jpg GRAPHIC 46403
11 GRAPHIC g884922ex99_2s7gbgd.jpg GRAPHIC 58980
12 GRAPHIC g884922ex99_2s8gbgd.jpg GRAPHIC 32985
13 GRAPHIC g884922im1.jpg GRAPHIC 8722
  Complete submission text file 0001193125-15-079008.txt   926477
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 15678215
SIC: 2834 Pharmaceutical Preparations